HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi Voted Company Of The Year At OTC Marketing Awards 2023

Executive Summary

Winners across 14 categories were announced at the OTC Marketing Awards 2023 on 23 November, with Sanofi crowned OTC Company of the Year.

Sanofi has been voted OTC Company of the Year securing the top prize at the OTC Marketing Awards 2023.

At a gala dinner held in London on 23 November to celebrate the achievements of the consumer health industry, Sanofi was the night’s biggest winner taking home four awards in total.

The annual OTC Marketing Awards – which is now in its 28th year – rewards outstanding achievement in the UK’s consumer health market, from product launches to digital campaigns and packaging changes, across 14 categories. This year’s event was sponsored by Kenvue, along with Dexcel Pharma, HH Global, Inspiros Consulting, Precision, and Skills in Healthcare, and supported by UK consumer healthcare association PAGB.

Winners By Category

Sanofi earned the OTC Company of the Year award for the outstanding launch of Cialis Together following an Rx-to-OTC switch, according to the panel of expert judges, as well as for its success in establishing Allevia as a go-to option in pharmacy for allergy relief.

These achievements were reflected in wins for Sanofi in the OTC Brand of the Year category – with Allevia taking the prize – and OTC Launch of the Year, which was awarded to Cialis Together.

The OTC Brand Revitalisation of the Year award went to Bayer’s Germoloids for effectively using consumer feedback to breathe new life into the established brand.

Most Innovative New OTC Product was awarded to Novo Nordisk’s Gina 10 micrograms vaginal tablets for introducing the first Hormone Replacement Therapy drug available without a prescription in the UK, while the award for Best OTC Packaging Design was handed to Kenvue’s Benylin for an innovative and modern design which tied together a diverse product range.

Offering a different take on erectile dysfunction which delivered results ensured Eroxon – from Futura Medical, Ceuta Healthcare and Cooper Consumer Health – secured the award for Best Big Budget OTC Marketing Campaign, while the award for Best Niche OTC Marketing Campaign went to Viatris’ Difflam for producing an eye-catching and quirky creative.

Viatris’s Difflam also grabbed the award for Best OTC Digital or Mobile Marketing for its innovative use of geo and proximity advertising, while Perrigo’s Beconase took home the award for Best OTC Audio-Visual Advertising for cutting through the fluff around hay fever ads.

Effectively communicating the key benefits over other OTC options ensured Sanofi’s Allevia won the award for Best OTC Pharmacy Training & Learning, while Reckitt’s Nurofen earned the Best OTC Public Relations Campaign for a Consumer Healthcare Product award for shining a light on the under-recognized issue of women’s pain.

Attention-grabbing creatives which drove increased market share helped Thornton & Ross’ Hedrin win the award for Best OTC Social Media Campaign, while Kenvue’s Nicorette QuickMist was presented with the Best OTC Trade Advertising & Sales Support award for a campaign with the potential to disrupt the trend towards vaping.

Check out the full list of winning and highly-commended entries at the OTC Marketing Awards website

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154218

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel